SCOTUS holds patents in Alice v CLS ineligible

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SCOTUS holds patents in Alice v CLS ineligible

The Supreme Court has affirmed the Federal Circuit’s judgment in its long-awaited Alice v CLS opinion

supreme20court300.jpg

“Because the claims are drawn to a patent-ineligible abstract idea, they are not patent eligible under §101,” said the Supreme Court.

Justice Clarence Thomas delivered the unanimous opinion, while Justice Sonia Sotomayor filed a concurring opinion in which Justice Ruth Bader Ginsberg and Justice Stephen Breyer joined.

The patents at issue in the case disclose a computer-implemented scheme for mitigating settlement risk in financial transactions by using a third-party intermediary. The question the Supreme Court was asked to answer was whether the claims presented are patent eligible under Section 101 of the Patent Act or instead are drawn to a patent-ineligible idea.

The Supreme Court explained that it had long held that Section 101 contains an implicit exception for laws of nature, natural phenomena, and abstract ideas, such as in its Association for Molecular Pathology v Myriad Genetics decision. The Court noted that in applying the Section 101 exception, it must distinguish patents that claim the “building blocks” of human ingenuity, which are ineligible for patent protection, from those that integrate the building blocks into something more, thereby “transforming” them into a patent-eligible invention. This was an issue the Supreme Court explored in its Mayo Collaborative Services v Prometheus Laboratories decision.

The Supreme Court said that using this Mayo framework it must first determine whether the claims at issue are directed to a patent-ineligible concept and, if so, whether the claim’s elements transform the nature of the claim into a patent-eligible application.

The Court said the patents in Alice relate to an abstract idea. “Turning to the second step of Mayo’s framework: The method claims, which merely require generic computer implementation, fail to transform that abstract idea in to a patent-eligible invention,” said the Court.

It said simply adding conventional steps to a method “well known in the art” is not enough and that the “introduction of a computer into the claims does not alter the anlaysis”.

“Here, the representative method claim does no more than simply instruct the practitioner to implement the abstract idea of intermediated settlement on a generic computer,” said the Court.

The concurring opinion written by Justice Sotomayor agreed with the view that any “claim that merely describes a method of doing business does not qualify as a ’process’ under §101”. But Sotomayor added: “As in Bilski, however, I further believe that the method claims at issue are drawn to an abstract idea.”

Visit www.managingip.com for in-depth analysis of the opinion and its ramifications.

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article